• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

作者信息

Holt D W, Mueller E A, Kovarik J M, van Bree J B, Kutz K

机构信息

Analytical Unit, St George's Hospital Medical School, London, United Kingdom.

出版信息

Transplant Proc. 1994 Oct;26(5):2935-9.

PMID:7940927
Abstract
摘要

相似文献

1
The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.新山地明（Sandimmun Neoral）的药代动力学：环孢素的一种新口服制剂
Transplant Proc. 1994 Oct;26(5):2935-9.
2
Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in pediatric patients.
Transplant Proc. 1994 Oct;26(5):2973-4.
3
Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
Transplant Proc. 1995 Feb;27(1):1434-7.
4
Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Transplant Proc. 1996 Dec;28(6):3140-1.
5
Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.心脏移植受者术后即刻口服环孢素（新山地明）的药代动力学
Transpl Int. 2002 Dec;15(12):649-54. doi: 10.1007/s00147-002-0491-0. Epub 2002 Nov 22.
6
Enhanced absorption of new oral cyclosporin microemulsion formulation, Neoral, in liver transplant recipients with external biliary diversion.
Transplant Proc. 1994 Oct;26(5):2977-8.
7
[Variability of the bioavailability of cyclosporine: benefit of the Neoral formulation].[环孢素生物利用度的变异性：新山地明制剂的益处]
Therapie. 1997 Jul-Aug;52(4):353-7.
8
Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
Transplant Proc. 1996 Aug;28(4):2270-2.
9
Preliminary pharmacokinetic evaluation of a new galenical formulation of oral cyclosporine A: Neoral TM.
Transplant Proc. 1995 Apr;27(2):1813-4.
10
Relative bioavailability of Sandimmune and Sandimmune Neoral in pediatric liver recipients.
Transplant Proc. 1994 Oct;26(5):2979-80.

引用本文的文献

1
Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis.新型钙调神经磷酸酶抑制剂voclosporin对实验性结肠炎的保护作用。
Front Med (Lausanne). 2023 Jun 9;10:1177450. doi: 10.3389/fmed.2023.1177450. eCollection 2023.
2
Biopharmaceutical insights of particulate emulsified systems - a prospective overview.微粒乳化系统的生物制药见解 - 前瞻性概述。
Lipids Health Dis. 2018 May 10;17(1):112. doi: 10.1186/s12944-018-0757-x.
3
A review on therapeutic drug monitoring of immunosuppressant drugs.免疫抑制剂治疗药物监测的综述。
Iran J Basic Med Sci. 2011 Nov;14(6):485-98.
4
Prediction of drug solubility in lipid mixtures from the individual ingredients.从各成分预测脂混合物中的药物溶解度。
AAPS PharmSciTech. 2012 Dec;13(4):1103-9. doi: 10.1208/s12249-012-9830-3. Epub 2012 Aug 21.
5
Clinical studies with oral lipid based formulations of poorly soluble compounds.口服脂基制剂改善难溶性化合物的临床研究。
Ther Clin Risk Manag. 2007 Aug;3(4):591-604.
6
[Cyclosporine monitoring in patients with chronic uveitis].
Ophthalmologe. 2005 Apr;102(4):349-54. doi: 10.1007/s00347-005-1174-x.
7
Cyclosporin for refractory ulcerative colitis.环孢素用于治疗难治性溃疡性结肠炎。
Gut. 2003 Feb;52(2):172-3. doi: 10.1136/gut.52.2.172.
8
Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats.
Pharm Res. 2002 Sep;19(9):1362-7. doi: 10.1023/a:1020363111398.
9
Therapeutic drug monitoring of immunosuppressant drugs.免疫抑制药物的治疗药物监测
Br J Clin Pharmacol. 1999 Apr;47(4):339-50. doi: 10.1046/j.1365-2125.1999.00911.x.
10
Prevention of transplant rejection: current treatment guidelines and future developments.移植排斥反应的预防：当前治疗指南与未来发展
Drugs. 1997 Oct;54(4):533-70. doi: 10.2165/00003495-199754040-00003.